Fidelity Investments’s NanoViricides NNVC Stock Holding History

Fidelity Investments’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.12K	Buy	1,536 +1,424	+1,271%	+$1.95K	﹤0.01%	5146
2026 Q1	$102	Buy	+112	New	+$117	﹤0.01%	5262
2025 Q4	–	Sell	-36	Closed	-$51	–	5534
2025 Q3	$51	Hold	36	–	–	﹤0.01%	5237
2025 Q2	$50	Buy	+36	New	+$49	﹤0.01%	5175
2025 Q1	–	Sell	-86	Closed	-$123	–	5570
2024 Q4	$123	Buy	+86	New	+$124	﹤0.01%	5084
2024 Q1	–	Sell	-100	Closed	-$102	–	5597
2023 Q4	$102	Buy	+100	New	+$116	﹤0.01%	4941
2023 Q2	–	Sell	-1	Closed	-$1	–	5527
2023 Q1	$1	Buy	+1	New	+$1	﹤0.01%	5242
2022 Q2	–	Sell	-3	Closed	–	–	5312
2022 Q1	$0	Hold	3	–	–	﹤0.01%	5315
2021 Q4	$0	Sell	3 -47	-94%	-$214	﹤0.01%	4746
2021 Q3	$0	Buy	+50	New	+$208	﹤0.01%	4805
2021 Q1	–	Sell	-3	Closed	–	–	4367
2020 Q4	$0	Buy	+3	New	+$11	﹤0.01%	4152
2019 Q3	–	Hold	0	–	–	–	4090
2019 Q2	–	Hold	0	–	–	–	4035
2019 Q1	–	Hold	0	–	–	–	4013
2018 Q4	–	Hold	0	–	–	–	3933
2018 Q3	–	Hold	0	–	–	–	3709

Other funds holding NNVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Fidelity Investments's NNVC Position: Q2 2026 in Review

Fidelity Investments increased its NanoViricides (NNVC) stake by 1,271% in Q2 2026, buying an estimated $1.95K and bringing the position to 1,536 shares worth $2.12K. The position accounts for ﹤0.01% of the portfolio, ranked #5146.

Fidelity Investments first reported a position in NNVC in Q4 2020 and has held it in 11 quarters since. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

Fidelity Investments held 1,536 shares of NanoViricides worth $2.12K as of Q2 2026.
Fidelity Investments bought 1,424 NanoViricides shares in Q2 2026, an estimated $1.95K.
NanoViricides made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5146 holding.
Fidelity Investments first reported a position in NanoViricides in Q4 2020 and has held it in 11 quarters since.
48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.